TotalMarketCap

Cel Sci

CVMNYSE United StatesHealth CareBiotechnology: Biological Products (No Diagnostic Substances)

Market cap

$24.625 M

$1.40 +1.45%

Close of 6 Nov 2026

As of 6 Nov 2026, Cel Sci (CVM) has a market capitalization of $24.6M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$25.4M

Loss-making

Shares outstanding

17,588,987

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 163 →
  1. #135Metagenomi TherapeuticsMGX$27.7M
  2. #136Evaxion A/SEVAX$25.5M
  3. #137Cel SciCVM$24.6M
  4. #138BioStem TechnologiesBSEM$19.4M
  5. #139Black Hawk AcquisitionBKHA$18.7M

What if Cel Sci were worth as much as…

Open the what-if tool →

Gold $28.2T

$1,605,372

Per share 1,146,695× higher

Bitcoin $1.53T

$86,863.90

Per share 62,046× higher

Apple $5.02T

$285,166.09

Per share 203,690× higher

Or at a round number

$50.0M$100.0M$200.0M$500.0M

Where these numbers come from

Share counts and financials for Cel Sci are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.